122 related articles for article (PubMed ID: 28834540)
1. CCL18-dependent translocation of AMAP1 is critical for epithelial to mesenchymal transition in breast cancer.
Li H; Zhang D; Yu J; Liu H; Chen Z; Zhong H; Wan Y
J Cell Physiol; 2018 Apr; 233(4):3207-3217. PubMed ID: 28834540
[TBL] [Abstract][Full Text] [Related]
2. CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma.
Lin Z; Li W; Zhang H; Wu W; Peng Y; Zeng Y; Wan Y; Wang J; Ouyang N
Tumour Biol; 2016 Mar; 37(3):3461-8. PubMed ID: 26449829
[TBL] [Abstract][Full Text] [Related]
3. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
[TBL] [Abstract][Full Text] [Related]
4. Pyk2 and Src mediate signaling to CCL18-induced breast cancer metastasis.
Li HY; Cui XY; Wu W; Yu FY; Yao HR; Liu Q; Song EW; Chen JQ
J Cell Biochem; 2014 Mar; 115(3):596-603. PubMed ID: 24142406
[TBL] [Abstract][Full Text] [Related]
5. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
6. AMAP1 as a negative-feedback regulator of nuclear factor-κB under inflammatory conditions.
Tien DN; Kishihata M; Yoshikawa A; Hashimoto A; Sabe H; Nishi E; Kamei K; Arai H; Kita T; Kimura T; Yokode M; Ashida N
Sci Rep; 2014 May; 4():5094. PubMed ID: 24865276
[TBL] [Abstract][Full Text] [Related]
7. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
[TBL] [Abstract][Full Text] [Related]
8. CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling.
Lane D; Matte I; Laplante C; Garde-Granger P; Carignan A; Bessette P; Rancourt C; Piché A
Mol Cancer; 2016 Sep; 15(1):58. PubMed ID: 27613122
[TBL] [Abstract][Full Text] [Related]
9. CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.
Lin X; Chen L; Yao Y; Zhao R; Cui X; Chen J; Hou K; Zhang M; Su F; Chen J; Song E
Oncotarget; 2015 Aug; 6(24):20485-99. PubMed ID: 26244871
[TBL] [Abstract][Full Text] [Related]
10. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
11. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
12. Acetylation of ACAP4 regulates CCL18-elicited breast cancer cell migration and invasion.
Song X; Liu W; Yuan X; Jiang J; Wang W; Mullen M; Zhao X; Zhang Y; Liu F; Du S; Rehman A; Tian R; Li J; Frost A; Song Z; Green HN; Henry C; Liu X; Ding X; Wang D; Yao X
J Mol Cell Biol; 2018 Dec; 10(6):559-572. PubMed ID: 30395269
[TBL] [Abstract][Full Text] [Related]
13. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities.
Onodera Y; Hashimoto S; Hashimoto A; Morishige M; Mazaki Y; Yamada A; Ogawa E; Adachi M; Sakurai T; Manabe T; Wada H; Matsuura N; Sabe H
EMBO J; 2005 Mar; 24(5):963-73. PubMed ID: 15719014
[TBL] [Abstract][Full Text] [Related]
14. CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-κB signaling pathway.
Hou X; Zhang Y; Qiao H
Tumour Biol; 2016 Jan; 37(1):641-51. PubMed ID: 26242263
[TBL] [Abstract][Full Text] [Related]
15. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
[TBL] [Abstract][Full Text] [Related]
16. Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis.
Hashimoto S; Hirose M; Hashimoto A; Morishige M; Yamada A; Hosaka H; Akagi K; Ogawa E; Oneyama C; Agatsuma T; Okada M; Kobayashi H; Wada H; Nakano H; Ikegami T; Nakagawa A; Sabe H
Proc Natl Acad Sci U S A; 2006 May; 103(18):7036-41. PubMed ID: 16636290
[TBL] [Abstract][Full Text] [Related]
17. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.
Nam JM; Onodera Y; Mazaki Y; Miyoshi H; Hashimoto S; Sabe H
EMBO J; 2007 Feb; 26(3):647-56. PubMed ID: 17255943
[TBL] [Abstract][Full Text] [Related]
18. Discovery of CCL18 antagonist blocking breast cancer metastasis.
Liu Y; Zheng H; Li Q; Li S; Lai H; Song E; Li D; Chen J
Clin Exp Metastasis; 2019 Jun; 36(3):243-255. PubMed ID: 31062206
[TBL] [Abstract][Full Text] [Related]
19. CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6/Src/PI3K/Akt pathway.
Huang X; Lai S; Qu F; Li Z; Fu X; Li Q; Zhong X; Wang C; Li H
Mol Ther Oncolytics; 2022 Jun; 25():1-15. PubMed ID: 35399607
[TBL] [Abstract][Full Text] [Related]
20. CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH-NF-κB signalling pathway.
Qin Y; Wang J; Zhu G; Li G; Tan H; Chen C; Pi L; She L; Chen X; Wei M; Li Z; Liu Z; Huang D; Liu Y; Zhang X
J Cell Mol Med; 2019 Apr; 23(4):2689-2701. PubMed ID: 30768878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]